Betel quid chewing leads to the development of unique de novo malignancies in liver transplant recipients, a retrospective single center study in Taiwan.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27631265)

Published in Medicine (Baltimore) on September 01, 2016

Authors

Yi-Chan Chen1, Chih-Hsien Cheng, Yu-Chao Wang, Ting-Jun Wu, Hong-Shiue Chou, Kun-Ming Chan, Wei-Chen Lee, Chen-Fang Lee, Ruey Shyang Soong

Author Affiliations

1: aDepartment of General Surgery, Keelung Chang Gung Memorial Hospital, Keelung City, Anle District bSchool of Medicine, Chang Gung University cDepartment of Liver and Transplantation Surgery, Linkou Chang Gung Memorial Hospital, Guishan District, Taoyuan City, Taiwan.

Articles cited by this

Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99

Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis (2005) 4.51

Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum (2004) 3.29

Cancer immunoediting from immune surveillance to immune escape. Immunology (2007) 3.03

AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology (2005) 2.90

Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer (2003) 2.64

National Institutes of Health Consensus Development Conference Statement: liver transplantation--June 20-23, 1983. Hepatology (1984) 2.50

Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl (2004) 2.31

Increased cancer risk after liver transplantation: a population-based study. J Hepatol (2001) 2.25

Preventable exposures associated with human cancers. J Natl Cancer Inst (2011) 2.14

Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl (2008) 1.97

Smoking, alcohol drinking, occupational exposures and social inequalities in hypopharyngeal and laryngeal cancer. Int J Epidemiol (2004) 1.66

Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci (2008) 1.53

Visual screening of oral cavity cancer in a male population: experience from a medical center. J Chin Med Assoc (2011) 1.43

Current status and future of liver transplantation. Semin Liver Dis (2010) 1.40

Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol (2007) 1.37

Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study. Int J Cancer (2012) 1.36

Epidemiological survey of oral submucous fibrosis and leukoplakia in aborigines of Taiwan. J Oral Pathol Med (2001) 1.32

De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl (2001) 1.30

Effect of cigarette smoking and alcohol consumption in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Epidemiol (1991) 1.28

Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes. Clin Cancer Res (2011) 1.25

Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J Oral Pathol Med (2005) 1.23

Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. Ann Surg (2008) 1.22

Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival. Am J Transplant (2006) 1.20

Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology (2009) 1.18

Control of oral cancer in developing countries. A WHO meeting. Bull World Health Organ (1984) 1.14

Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int (2010) 1.14

Survival of second and multiple primary tumors in patients with oral cavity squamous cell carcinoma in the betel quid chewing area. Oral Oncol (2006) 1.12

Different impact from betel quid, alcohol and cigarette: risk factors for pharyngeal and laryngeal cancer. Int J Cancer (2005) 1.11

Burden of de novo malignancy in the liver transplant recipient. Liver Transpl (2012) 1.07

Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. Transplantation (2000) 1.06

Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation (2005) 1.05

Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation (1999) 1.05

Kaposi's sarcoma in transplant recipients. Transplantation (1997) 1.05

De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry. Transplant Proc (2012) 1.01

Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. Dig Liver Dis (2009) 1.01

Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma. J Hepatol (2013) 1.00

De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant (2006) 0.99

Non-lymphoid cancer after liver transplantation. Hepatogastroenterology (1997) 0.94

Liver transplantation: immunosuppression and oncology. Curr Opin Organ Transplant (2014) 0.94

De novo malignancy post-liver transplantation: a single center, population controlled study. Clin Transplant (2013) 0.91

De novo tumors after orthotopic liver transplantation. Transplant Proc (2002) 0.90

Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation (2001) 0.89

De novo malignancies following liver transplantation: results from a multicentric study in central and southern Italy, 1990-2008. Transplant Proc (2013) 0.88

De novo tumors are a major cause of late mortality after orthotopic liver transplantation. Transplant Proc (2009) 0.88

Malignancy following liver transplantation: a report from the Australian Combined Liver Transplant Registry. Transplant Proc (1995) 0.87

Epidemiology of post-transplant malignancy in Asian renal transplant recipients: a population-based study. Int Urol Nephrol (2013) 0.86

De novo malignancies after adult-to-adult living-donor liver transplantation with a malignancy surveillance program: comparison with a Japanese population-based study. Transplantation (2013) 0.85

De novo malignancies in liver transplantation. Transplant Proc (2003) 0.85

Malignancy after liver transplantation: cumulative risk for development. Transplant Proc (2009) 0.83

De novo malignant disease after liver transplantation? Risk and surveillance strategies. Liver Transpl (2013) 0.78

De novo cancers following liver transplantation: a single center experience in China. PLoS One (2014) 0.77

Screening for head and neck cancer in liver transplant candidates: a review of 11 years of experience at the University of Pittsburgh. Laryngoscope (2011) 0.77

Development of lymphoproliferative disease after liver transplantation. Transplant Proc (2008) 0.76

Effects of converting tacrolimus formulation from twice-daily to once-daily in liver transplantation recipients. Biomed Res Int (2014) 0.76

Articles by these authors

Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage. J Hepatol (2009) 1.82

Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology (2010) 1.77

Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma. J Surg Oncol (2012) 1.63

Predictors of long-term disease-free survival after resection of hepatocellular carcinoma: two decades of experience at Chang Gung Memorial Hospital. Ann Surg Oncol (2003) 1.60

Adverse outcomes in patients with postoperative ascites after liver resection for hepatocellular carcinoma. World J Surg (2012) 1.56

Significance of tumor necrosis for outcome of patients with hepatocellular carcinoma receiving locoregional therapy prior to liver transplantation. Ann Surg Oncol (2011) 1.50

Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol (2002) 1.47

Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system. PLoS One (2011) 1.45

Complete mitochondrial genomes of Taenia multiceps, T. hydatigena and T. pisiformis: additional molecular markers for a tapeworm genus of human and animal health significance. BMC Genomics (2010) 1.43

Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospital. Ann Surg Oncol (2003) 1.34

Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg (2004) 1.28

Identification of transcription factor cooperativity via stochastic system model. Bioinformatics (2006) 1.25

Reliability of a new ultrasonic cardiac output monitor in recipients of living donor liver transplantation. Liver Transpl (2008) 1.23

Adenosquamous/squamous cell carcinoma of the gallbladder. J Surg Oncol (2007) 1.16

Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience. Surgery (2009) 1.16

A new measure of the robustness of biochemical networks. Bioinformatics (2005) 1.13

Splenic angiosarcoma metastasis to small bowel presented with gastrointestinal bleeding. World J Gastroenterol (2005) 1.12

Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma. PLoS One (2012) 1.10

Scoring short-term mortality after liver transplantation. Liver Transpl (2010) 1.05

Thermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug release. Nanotechnology (2009) 1.04

On the attenuation and amplification of molecular noise in genetic regulatory networks. BMC Bioinformatics (2006) 1.04

Pedunculated hepatocellular carcinoma: clinicopathologic study of 18 surgically resected cases. World J Surg (2002) 1.03

Surgical management of giant hepatic hemangiomas: complications and review of the literature. Chang Gung Med J (2012) 1.02

CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection. BMC Cancer (2009) 1.02

Pre-operative risk factors predict post-operative respiratory failure after liver transplantation. PLoS One (2011) 1.00

Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection. Ann Surg (2012) 1.00

Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg (2003) 1.00

ES-cell derived hematopoietic cells induce transplantation tolerance. PLoS One (2008) 0.99

Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin. Ann Surg Oncol (2011) 0.98

Clinicopathological features and prognostic factors of gastric cancer patients aged 40 years or younger. J Surg Oncol (2012) 0.97

Robust H infinity-stabilization design in gene networks under stochastic molecular noises: fuzzy-interpolation approach. IEEE Trans Syst Man Cybern B Cybern (2008) 0.95

The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma. Surgery (2011) 0.95

Alkaline phosphatase: does it have a role in predicting hepatocellular carcinoma recurrence? J Gastrointest Surg (2011) 0.95

Surgical results in patients with hepatitis virus-related hepatocellular carcinoma in Taiwan. World J Surg (2002) 0.94

Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment. World J Surg Oncol (2011) 0.94

Dynamic cross-talk analysis among TNF-R, TLR-4 and IL-1R signalings in TNFalpha-induced inflammatory responses. BMC Med Genomics (2010) 0.93

Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma. World J Gastroenterol (2009) 0.93

Characterization of hepatocellular carcinoma recurrence after liver transplantation: perioperative prognostic factors, patterns, and outcome. Asian J Surg (2011) 0.92

The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood (2013) 0.92

Surgical resection of centrally located large hepatocellular carcinoma. Chang Gung Med J (2012) 0.91

Hepatitis C virus infection facilitates gallstone formation. J Gastroenterol Hepatol (2005) 0.91

Preoperative estimation of the liver graft weight in adult right lobe living donor liver transplantation using maximal portal vein diameters. Liver Transpl (2011) 0.90

Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection. Curr Opin Organ Transplant (2014) 0.89

HOXB4 but not BMP4 confers self-renewal properties to ES-derived hematopoietic progenitor cells. Transplantation (2008) 0.89

Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27. J Hepatol (2009) 0.88

Liver resection for complicated hepatocellular carcinoma: challenges but opportunity for long-term survivals. J Surg Oncol (2012) 0.87

Secreted ERBB3 isoforms are serum markers for early hepatoma in patients with chronic hepatitis and cirrhosis. J Proteome Res (2011) 0.86

Prognostic analysis of patients with pancreatic head adenocarcinoma less than 2 cm undergoing resection. World J Gastroenterol (2009) 0.86

Hepatic resection for hepatocellular carcinoma in elderly patients. Hepatogastroenterology (2004) 0.85

Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis. Immunobiology (2010) 0.85

Prognostic significance of the number of tumors and aggressive surgical approach in colorectal cancer hepatic metastasis. World J Surg Oncol (2014) 0.85

YTRP: a repository for yeast transcriptional regulatory pathways. Database (Oxford) (2014) 0.85

Using indocyanine green test to avoid post-hepatectomy liver dysfunction. Chang Gung Med J (2007) 0.84

Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway. Transplantation (2013) 0.84

Clinical experience of hepatic hemangioma undergoing hepatic resection. Dig Dis Sci (2003) 0.84

Differentially profiling the low-expression transcriptomes of human hepatoma using a novel SSH/microarray approach. BMC Genomics (2006) 0.84

Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol (2005) 0.84

Application of cryopreserved vein grafts as a conduit between the coronary vein and liver graft to reconstruct portal flow in adult living liver transplantation. Clin Transplant (2009) 0.84

Robust model matching design methodology for a stochastic synthetic gene network. Math Biosci (2011) 0.84

Clinical perspective of acute humoral rejection after blood type-compatible liver transplantation. Transplantation (2011) 0.83

Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome. Asian J Surg (2011) 0.83

A case of huge primary liposarcoma in the liver. World J Gastroenterol (2006) 0.83

Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome. Ann Surg Oncol (2013) 0.82

Identification of NV-F virus DNA in hepatocellular carcinoma. J Med Virol (2007) 0.82